Neogen Corporation (NEOG) Research

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Market snapshot

Symbol
NEOG
Price
$9.31
Day change
+4.26%
Market cap
$2.0B
P/E ratio
-3.33x
52-week range
4.56-11.43
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Next earnings
in 2 months
Analyst price target
$11.00

Recent news

  • Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results

    U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 points on Thursday.

  • Neogen Stock Tumbles. Why a Guidance Hike and Earnings Beat Aren't Helping.

    Neogen's animal safety business is a drag on earnings in the face of ‘third-party' setbacks.

  • Neogen Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

    Neogen Corporation (NASDAQ: NEOG) will release earnings for its third quarter before the opening bell on Thursday, April 9.

Peer companies

  • Azenta, Inc. (AZTA)
  • BioLife Solutions, Inc. (BLFS)
  • CONMED Corporation (CNMD)
  • Kestra Medical Technologies, Ltd. (KMTS)
  • Intellia Therapeutics, Inc. (NTLA)
  • NovoCure Limited (NVCR)
  • OPKO Health, Inc. (OPK)
  • Tilray Brands, Inc. (TLRY)

Recent insider activity

  • Moylan John Patrick — F-InKind (2553 shares) on 2026-06-03
  • Rocklin Amy M — M-Exempt (35183 shares) on 2026-05-18
  • Rocklin Amy M — F-InKind (10241 shares) on 2026-05-18
  • Rocklin Amy M — M-Exempt (35183 shares) on 2026-05-18
  • Moylan John Patrick — M-Exempt (4558 shares) on 2026-05-04

Open Neogen Corporation (NEOG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.